Private Private
Nanosynex
Rapid Diagnostic Test for Bacterial Infections
ABOUT

Nanosynex is a diagnostic test that checks bacterial resistance to antibiotics in a record time, using a phenotypic approach that involves microfluidic techniques and fluorescent-based analysis.

The test helps doctors determine faster (same-day results) the most appropriate antibiotic treatment for their patients, helping them recover in a shorter time and preventing the spread of resistant bacteria in the environment. By limiting prolonged hospitalization, Nanosynex allows to save significant healthcare costs.

Nanosynex solution will be sold to clinical laboratories as disposables cards and a fluorescent reading device.

The product is developed in the lab of Prof. Levenberg, Dean of the Technion Biomedical Engineering Faculty, and has a partnership with Biosynex, a French company in the rapid diagnostic industry with a distribution network in 60 countries.

Read More
Read Less
TAGS
VERTICAL MARKETS
TEAM
IN THE NEWS
RELATED COMPANIES
Add to Collection
Request intro
COMPANY PROFILE
GEOGRAPHICAL MARKETS
PRODUCTS
ISRAEL
Technion DRIVE Accelerator, Haifa, Israel
NANOSYNEX'S TIMELINE
NOW
Expand All